High content analysis of primary macrophages hosting proliferating Leishmania amastigotes: application to anti-leishmanial drug discovery.

<h4>Background/objectives</h4>Human leishmaniases are parasitic diseases causing severe morbidity and mortality. No vaccine is available and numerous factors limit the use of current therapies. There is thus an urgent need for innovative initiatives to identify new chemotypes displaying...

Full description

Saved in:
Bibliographic Details
Main Authors: Nathalie Aulner, Anne Danckaert, Eline Rouault-Hardoin, Julie Desrivot, Olivier Helynck, Pierre-Henri Commere, Hélène Munier-Lehmann, Gerald F Späth, Spencer L Shorte, Geneviève Milon, Eric Prina
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0002154&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841527065752371200
author Nathalie Aulner
Anne Danckaert
Eline Rouault-Hardoin
Julie Desrivot
Olivier Helynck
Pierre-Henri Commere
Hélène Munier-Lehmann
Gerald F Späth
Spencer L Shorte
Geneviève Milon
Eric Prina
author_facet Nathalie Aulner
Anne Danckaert
Eline Rouault-Hardoin
Julie Desrivot
Olivier Helynck
Pierre-Henri Commere
Hélène Munier-Lehmann
Gerald F Späth
Spencer L Shorte
Geneviève Milon
Eric Prina
author_sort Nathalie Aulner
collection DOAJ
description <h4>Background/objectives</h4>Human leishmaniases are parasitic diseases causing severe morbidity and mortality. No vaccine is available and numerous factors limit the use of current therapies. There is thus an urgent need for innovative initiatives to identify new chemotypes displaying selective activity against intracellular Leishmania amastigotes that develop and proliferate inside macrophages, thereby causing the pathology of leishmaniasis.<h4>Methodology/principal findings</h4>We have developed a biologically sound High Content Analysis assay, based on the use of homogeneous populations of primary mouse macrophages hosting Leishmania amazonensis amastigotes. In contrast to classical promastigote-based screens, our assay more closely mimics the environment where intracellular amastigotes are growing within acidic parasitophorous vacuoles of their host cells. This multi-parametric assay provides quantitative data that accurately monitors the parasitic load of amastigotes-hosting macrophage cultures for the discovery of leishmanicidal compounds, but also their potential toxic effect on host macrophages. We validated our approach by using a small set of compounds of leishmanicidal drugs and recently published chemical entities. Based on their intramacrophagic leishmanicidal activity and their toxicity against host cells, compounds were classified as irrelevant or relevant for entering the next step in the drug discovery pipeline.<h4>Conclusions/significance</h4>Our assay represents a new screening platform that overcomes several limitations in anti-leishmanial drug discovery. First, the ability to detect toxicity on primary macrophages allows for discovery of compounds able to cross the membranes of macrophage, vacuole and amastigote, thereby accelerating the hit to lead development process for compounds selectively targeting intracellular parasites. Second, our assay allows discovery of anti-leishmanials that interfere with biological functions of the macrophage required for parasite development and growth, such as organelle trafficking/acidification or production of microbicidal effectors. These data thus validate a novel phenotypic screening assay using virulent Leishmania amastigotes growing inside primary macrophage to identify new chemical entities with bona fide drug potential.
format Article
id doaj-art-ef749132337f415c92693daac008c589
institution Kabale University
issn 1935-2727
1935-2735
language English
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj-art-ef749132337f415c92693daac008c5892025-01-16T05:32:28ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352013-01-0174e215410.1371/journal.pntd.0002154High content analysis of primary macrophages hosting proliferating Leishmania amastigotes: application to anti-leishmanial drug discovery.Nathalie AulnerAnne DanckaertEline Rouault-HardoinJulie DesrivotOlivier HelynckPierre-Henri CommereHélène Munier-LehmannGerald F SpäthSpencer L ShorteGeneviève MilonEric Prina<h4>Background/objectives</h4>Human leishmaniases are parasitic diseases causing severe morbidity and mortality. No vaccine is available and numerous factors limit the use of current therapies. There is thus an urgent need for innovative initiatives to identify new chemotypes displaying selective activity against intracellular Leishmania amastigotes that develop and proliferate inside macrophages, thereby causing the pathology of leishmaniasis.<h4>Methodology/principal findings</h4>We have developed a biologically sound High Content Analysis assay, based on the use of homogeneous populations of primary mouse macrophages hosting Leishmania amazonensis amastigotes. In contrast to classical promastigote-based screens, our assay more closely mimics the environment where intracellular amastigotes are growing within acidic parasitophorous vacuoles of their host cells. This multi-parametric assay provides quantitative data that accurately monitors the parasitic load of amastigotes-hosting macrophage cultures for the discovery of leishmanicidal compounds, but also their potential toxic effect on host macrophages. We validated our approach by using a small set of compounds of leishmanicidal drugs and recently published chemical entities. Based on their intramacrophagic leishmanicidal activity and their toxicity against host cells, compounds were classified as irrelevant or relevant for entering the next step in the drug discovery pipeline.<h4>Conclusions/significance</h4>Our assay represents a new screening platform that overcomes several limitations in anti-leishmanial drug discovery. First, the ability to detect toxicity on primary macrophages allows for discovery of compounds able to cross the membranes of macrophage, vacuole and amastigote, thereby accelerating the hit to lead development process for compounds selectively targeting intracellular parasites. Second, our assay allows discovery of anti-leishmanials that interfere with biological functions of the macrophage required for parasite development and growth, such as organelle trafficking/acidification or production of microbicidal effectors. These data thus validate a novel phenotypic screening assay using virulent Leishmania amastigotes growing inside primary macrophage to identify new chemical entities with bona fide drug potential.https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0002154&type=printable
spellingShingle Nathalie Aulner
Anne Danckaert
Eline Rouault-Hardoin
Julie Desrivot
Olivier Helynck
Pierre-Henri Commere
Hélène Munier-Lehmann
Gerald F Späth
Spencer L Shorte
Geneviève Milon
Eric Prina
High content analysis of primary macrophages hosting proliferating Leishmania amastigotes: application to anti-leishmanial drug discovery.
PLoS Neglected Tropical Diseases
title High content analysis of primary macrophages hosting proliferating Leishmania amastigotes: application to anti-leishmanial drug discovery.
title_full High content analysis of primary macrophages hosting proliferating Leishmania amastigotes: application to anti-leishmanial drug discovery.
title_fullStr High content analysis of primary macrophages hosting proliferating Leishmania amastigotes: application to anti-leishmanial drug discovery.
title_full_unstemmed High content analysis of primary macrophages hosting proliferating Leishmania amastigotes: application to anti-leishmanial drug discovery.
title_short High content analysis of primary macrophages hosting proliferating Leishmania amastigotes: application to anti-leishmanial drug discovery.
title_sort high content analysis of primary macrophages hosting proliferating leishmania amastigotes application to anti leishmanial drug discovery
url https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0002154&type=printable
work_keys_str_mv AT nathalieaulner highcontentanalysisofprimarymacrophageshostingproliferatingleishmaniaamastigotesapplicationtoantileishmanialdrugdiscovery
AT annedanckaert highcontentanalysisofprimarymacrophageshostingproliferatingleishmaniaamastigotesapplicationtoantileishmanialdrugdiscovery
AT elinerouaulthardoin highcontentanalysisofprimarymacrophageshostingproliferatingleishmaniaamastigotesapplicationtoantileishmanialdrugdiscovery
AT juliedesrivot highcontentanalysisofprimarymacrophageshostingproliferatingleishmaniaamastigotesapplicationtoantileishmanialdrugdiscovery
AT olivierhelynck highcontentanalysisofprimarymacrophageshostingproliferatingleishmaniaamastigotesapplicationtoantileishmanialdrugdiscovery
AT pierrehenricommere highcontentanalysisofprimarymacrophageshostingproliferatingleishmaniaamastigotesapplicationtoantileishmanialdrugdiscovery
AT helenemunierlehmann highcontentanalysisofprimarymacrophageshostingproliferatingleishmaniaamastigotesapplicationtoantileishmanialdrugdiscovery
AT geraldfspath highcontentanalysisofprimarymacrophageshostingproliferatingleishmaniaamastigotesapplicationtoantileishmanialdrugdiscovery
AT spencerlshorte highcontentanalysisofprimarymacrophageshostingproliferatingleishmaniaamastigotesapplicationtoantileishmanialdrugdiscovery
AT genevievemilon highcontentanalysisofprimarymacrophageshostingproliferatingleishmaniaamastigotesapplicationtoantileishmanialdrugdiscovery
AT ericprina highcontentanalysisofprimarymacrophageshostingproliferatingleishmaniaamastigotesapplicationtoantileishmanialdrugdiscovery